The main market opportunities lie in developing precise CD22 targeted therapies for blood cancers, with over 20 ongoing clinical trials. Innovative technologies like TALEN® are enhancing cell-based ...

A team of Australian researchers have developed a new targeted therapeutic approach that could improve treatment for ...

Targeted therapies are cancer medications that work more selectively than standard chemotherapy medications. They do this by targeting specific molecules or genetic changes in cancer cells in order to ...

A research team at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) has developed a radiopharmaceutical molecule marker that ...

Published in the journal Blood, the research focuses on finding smarter ways to treat myelofibrosis by targeting the abnormal blood cells that drive the disease using immunotherapy, rather than just ...

A new clinical trial at HonorHealth Research Institute shows promise for treating advanced cutaneous squamous cell carcinoma using a targeted immune therapy. A patient with cutaneous squamous cell ...

A treatment that is effective against hearing loss caused by the 'MPZL2 gene' mutation has been developed. A research team led by Professor Jeong Jin-se of the otolaryngology department at Severance ...

Ongoing investigation into whether bee venom could help treat a certain type of cancer has been making "important progress," the leading researcher has told Newsweek. Experts at the Epigenetics Lab at ...

Neuroimmune diseases, such as multiple sclerosis, myasthenia gravis, and autoimmune encephalitis, are debilitating conditions ...